Atai Beckley, Inc. (ATAI)

4.005 -0.16 (-3.96%) USD  |  NASDAQ  |  May 07, 16:00
4.05 +0.04 (+1.12%) After-Hours: 07:26
More

Atai Beckley Research and Development Expense (Annual) : 53.06M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ATAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Definium Therapeutics, Inc. 117.66M
Compass Pathways Plc 118.71M
GH Research Plc 38.73M
Eli Lilly & Co. 13.34B
Nektar Therapeutics 117.07M